Paul Studenic

@Stiddyo

MD PhD│ Clinician in Internal Medicine and Rheumatology │ Clinical and translational Researcher │

Vrijeme pridruživanja: studeni 2010.

Tweetovi

Blokirali ste korisnika/cu @Stiddyo

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Stiddyo

  1. proslijedio/la je Tweet
    23. sij

    We're delighted that RMD Open is now indexed by MEDLINE! (NLM ID: 101662038) Congratulations to the editorial team and thanks to our authors and reviewers for helping us to publish high quality content. Explore the content archive at

    Poništi
  2. proslijedio/la je Tweet
    16. sij

    ✏️ The poll for the paper of the month is out! Only one day left to cast your vote!

    Poništi
  3. 13. sij

    It was a pleasure to reflect on the daily important topic of to treatments within this editorial. On ongoing puzzle...

    Poništi
  4. proslijedio/la je Tweet
    7. sij

    The poll for the paper of the month is out! Take a minute to cast your vote!

    Poništi
  5. proslijedio/la je Tweet
    4. sij

    Run Luke run Luke! Awww to late.

    Poništi
  6. proslijedio/la je Tweet
    29. pro 2019.

    Watch this AMAZING dynamic MRI showing what happens to airway with various anatomical head and neck positions This is exactly why basic airway maneuvers save lives!

    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet

    Sir William Osler, the father of modern medicine, died on this day 100 years ago. In his honor, I'm posting some of his memorable quotes. First set on the practice of medicine

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    27. pro 2019.

    “AI systems sometimes learn to make predictions based on factors that have less to do with disease than the brand of MRI machine used, the time a blood test is taken or whether a patient was visited by a chaplain”

    Poništi
  9. 21. pro 2019.
    Poništi
  10. proslijedio/la je Tweet
    8. pro 2019.

    Inaugural session for in . Coming together to beat !

    Poništi
  11. proslijedio/la je Tweet

    REVIEW | IL-12, IL-23 and IL-17 in immunobiology and therapeutic targeting

    Poništi
  12. 28. stu 2019.

    The perfect crema - it worked out finally! Product of my new

    Poništi
  13. proslijedio/la je Tweet
    19. stu 2019.

    Help us make rheumatology gender equitable by completing this EULAR-EMEUNET survey

    Poništi
  14. proslijedio/la je Tweet
    10. stu 2019.

    Erika Mosor presenting results of part 1 of project. Results of this qualitative study outline the priorities of young people with arthritis in patient-reported assessment at

    Poništi
  15. proslijedio/la je Tweet
    7. stu 2019.

    Visiting ? We are happy to meet you at the booth of the Annals of the rheumatic diseases!

    Tweet je nedostupan.
    Poništi
  16. proslijedio/la je Tweet
    6. stu 2019.

    Life is about balance: this new study published in and reported by emphasises the importance of considering the balance of bone and vascular health mediated by statins: Statins May Affect Your Bone Health

    Poništi
  17. proslijedio/la je Tweet

    To know more about the causes, mechanisms and management of , a condition characterized by presence of in the serum, check out this PrimeView

    Poništi
  18. 19. lis 2019.

    Can you imagine to never need to systematically collect variables any longer, but simply put your in a black box and it answers your question?

    Poništi
  19. proslijedio/la je Tweet
    15. lis 2019.

    You are a medical resident in a European country, I have a resident position in my rheumatology department, Saint-Antoine Hospital, (Sorbonne U), Paris, for 6 months, starting in November. French speaking required Contact: francis.berenbaum@aphp.fr Thank you for your RTs

    Poništi
  20. proslijedio/la je Tweet
    16. lis 2019.

    Today EULAR Young PARE is represented by Peter Boyd during the Conference! Watch the live stream at 14:30 CET - Can health policies help people with chronic diseases participate in the labor market? We are looking forward !

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·